Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease.

Alzheimer's Disease Neuroinflammation beta-amyloid blood-brain barrier microglia neuro-glial interactions neurodegeneration

Journal

Pharmacological reviews
ISSN: 1521-0081
Titre abrégé: Pharmacol Rev
Pays: United States
ID NLM: 0421737

Informations de publication

Date de publication:
07 Oct 2024
Historique:
accepted: 13 09 2024
received: 14 12 2023
revised: 25 07 2024
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 7 10 2024
Statut: aheadofprint

Résumé

Neuritic plaques are pathognomonic and terminal lesions of Alzheimer's Disease (AD). They embody AD pathogenesis because they harbor in one space critical pathologic features of the disease: amyloid deposits, neurofibrillary degeneration (NFD), neuroinflammation, iron accumulation. Neuritic plaques are thought to arise from the conversion of diffuse extracellular deposits of amyloid beta protein (Aβ), and it is believed that during conversion amyloid toxicity creates the dystrophic neurites of neuritic plaques, as well as neurofibrillary tangles (NFTs). However, recent evidence from human post-mortem studies suggests a much different mechanism of neuritic plaque formation where the first step in their creation is neuronal degeneration driven by iron overload and ferroptosis. Similarly, NFTs represent corpses of iron-laden neurons that develop independent of Aβ deposits. In this review, we will focus on the role of free redox-active iron in the development of typical AD pathology, as determined largely by evidence obtained in human temporal lobe during early, preclinical stages of AD. The findings have allowed construction of a scheme of AD pathogenesis where brain iron is center stage and is involved in every step of the sequence of events that produce characteristic AD pathology. We will discuss how the study of preclinical AD has produced a fresh and revised assessment of AD pathogenesis that may be important for reconsidering current therapeutic efforts and guiding future ones.

Identifiants

pubmed: 39375045
pii: pharmrev.123.000823
doi: 10.1124/pharmrev.123.000823
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Pharmacology and Experimental Therapeutics.

Auteurs

Wolfgang J Streit (WJ)

Department of Neuroscience, University of Florida, United States pschorr@ufl.edu.

Leah Phan (L)

University of Florida, United States.

Ingo Bechmann (I)

University of Leipzig, Germany.

Classifications MeSH